BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 19097760)

  • 1. Predominance of CTX-M-15 extended spectrum beta-lactamases in diverse Escherichia coli and Klebsiella pneumoniae from hospital and community patients in Kuwait.
    Ensor VM; Jamal W; Rotimi VO; Evans JT; Hawkey PM
    Int J Antimicrob Agents; 2009 May; 33(5):487-9. PubMed ID: 19097760
    [No Abstract]   [Full Text] [Related]  

  • 2. Dominance of CTX-M-2 and CTX-M-56 among extended-spectrum beta-lactamases produced by Klebsiella pneumoniae and Escherichia coli isolated in hospitals in Paraguay.
    Khan MA; Lemmens N; Riera E; Blonk T; Goedhart J; Van Belkum A; Goessens W; Hays JP; Van Westreenen M
    J Antimicrob Chemother; 2009 Dec; 64(6):1330-2. PubMed ID: 19854861
    [No Abstract]   [Full Text] [Related]  

  • 3. The emergence of a novel ceftazidime-resistant CTX-M extended-spectrum beta-lactamase, CTX-M-55, in both community-onset and hospital-acquired infections in Thailand.
    Kiratisin P; Apisarnthanarak A; Saifon P; Laesripa C; Kitphati R; Mundy LM
    Diagn Microbiol Infect Dis; 2007 Jul; 58(3):349-55. PubMed ID: 17449211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resistance to extended-spectrum beta-lactams by the emergence of SHV-12 and the loss of OmpK35 in Klebsiella pneumoniae and Escherichia coli in Malaysia.
    Palasubramaniam S; Muniandy S; Navaratnam P
    J Microbiol Immunol Infect; 2009 Apr; 42(2):129-33. PubMed ID: 19597644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in Spanish hospitals: 2nd multicenter study (GEIH-BLEE project, 2006)].
    Angel Díaz M; Ramón Hernández J; Martínez-Martínez L; Rodríguez-Baño J; Pascual A;
    Enferm Infecc Microbiol Clin; 2009 Nov; 27(9):503-10. PubMed ID: 19329230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prevalence of extended-spectrum beta-lactamases of the CTX-M type producing Escherichia coli and Klebsiella pneumoniae in Bretonneau hospitals (CHRU Tours)].
    Holstein A; Grillon A; Yzon L; Morange V; Baty G; Lartigue MF; Mereghetti L; Goudeau A; Lanotte P
    Pathol Biol (Paris); 2010 Feb; 58(1):67-9. PubMed ID: 19892477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emergence of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae during the years 2000 and 2004 in Helsinki, Finland.
    Forssten SD; Kolho E; Lauhio A; Lehtola L; Mero S; Oksaharju A; Jalava J; Tarkka E; Vaara M; Vuopio-Varkila J
    Clin Microbiol Infect; 2010 Aug; 16(8):1158-61. PubMed ID: 20670290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Mortality risk factors for bloodstream infections caused by extended-spectrum beta-lactamase-producing microorganisms].
    Ferrández O; Grau S; Saballs P; Luque S; Terradas R; Salas E
    Rev Clin Esp; 2011 Mar; 211(3):119-26. PubMed ID: 21371702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CMY-2, CMY-8b, and DHA-1 plasmid-mediated AmpC β-lactamases among clinical isolates of Escherichia coli and Klebsiella pneumoniae from a university hospital, Thailand.
    Singtohin S; Chanawong A; Lulitanond A; Sribenjalux P; Auncharoen A; Kaewkes W; Songsri J; Pienthaweechai K
    Diagn Microbiol Infect Dis; 2010 Nov; 68(3):271-7. PubMed ID: 20851550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spread of Klebsiella pneumoniae isolates producing OXA-48 β-lactamase in a Tunisian university hospital.
    Ktari S; Mnif B; Louati F; Rekik S; Mezghani S; Mahjoubi F; Hammami A
    J Antimicrob Chemother; 2011 Jul; 66(7):1644-6. PubMed ID: 21565807
    [No Abstract]   [Full Text] [Related]  

  • 11. Extended spectrum beta lactamase producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes.
    Shanthi M; Sekar U
    J Assoc Physicians India; 2010 Dec; 58 Suppl():41-4. PubMed ID: 21568008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extended spectrum beta-lactamases (ESBL) in Escherichia coli and Klebsiella pneumoniae: trends in the hospital and community settings.
    Khanfar HS; Bindayna KM; Senok AC; Botta GA
    J Infect Dev Ctries; 2009 May; 3(4):295-9. PubMed ID: 19759493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High frequency of beta-lactam susceptibility in CTX-M-type extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae, Escherichia coli and Proteus mirabilis according to the new CLSI recommendations.
    de Oliveira KR; de Freitas AL; Willers DM; Barth AL; Zavascki AP
    J Antimicrob Chemother; 2010 Nov; 65(11):2481-3. PubMed ID: 20846935
    [No Abstract]   [Full Text] [Related]  

  • 14. Prevalence and characterization of extended-spectrum beta-lactamases in Klebsiella pneumoniae in Algiers hospitals (Algeria).
    Messai Y; Iabadene H; Benhassine T; Alouache S; Tazir M; Gautier V; Arlet G; Bakour R
    Pathol Biol (Paris); 2008 Jul; 56(5):319-25. PubMed ID: 18585867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Re: A VIM-1-metallo-beta-lactamase-producing Klebsiella pneumoniae clinical isolate in an acute hospital in Germany.
    Shah PM
    Int J Antimicrob Agents; 2009 Oct; 34(4):381. PubMed ID: 19502012
    [No Abstract]   [Full Text] [Related]  

  • 16. Long-term study of Escherichia coli and Klebsiella pneumoniae isolates producing extended-spectrum beta-lactamases.
    Polwichai P; Trakulsomboon S; Dejsirilert S; Thongmali O; Sawanpanyalert P; Aswapokee N; Buppanharun W
    J Med Assoc Thai; 2009 Aug; 92 Suppl 4():S53-8. PubMed ID: 21294502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Control of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a children's hospital by changing antimicrobial agent usage policy.
    Lee J; Pai H; Kim YK; Kim NH; Eun BW; Kang HJ; Park KH; Choi EH; Shin HY; Kim EC; Lee HJ; Ahn HS
    J Antimicrob Chemother; 2007 Sep; 60(3):629-37. PubMed ID: 17599919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prevalence of extended-spectrum beta-lactamases in nosocomial Escherichia coli and Klebsiella spp. strains isolated from blood cultures].
    Zarakolu P; Metan G; Hasçelik G; Akova M
    Mikrobiyol Bul; 2007 Oct; 41(4):579-84. PubMed ID: 18173077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hospital and community-acquired β-lactamases-producing Escherichia coli and Klebsiella pneumoniae at hospitals in Hermosillo, Sonora].
    Navarro-Navarro M; Robles-Zepeda RE; Garibay-Escobar A; Ruiz-Bustos E
    Salud Publica Mex; 2011; 53(4):341-4. PubMed ID: 21986791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spread of CTX-M-type extended-spectrum beta-lactamases among bloodstream isolates of Escherichia coli and Klebsiella pneumoniae from a Korean hospital.
    Lee SG; Jeong SH; Lee H; Kim CK; Lee Y; Koh E; Chong Y; Lee K
    Diagn Microbiol Infect Dis; 2009 Jan; 63(1):76-80. PubMed ID: 19073302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.